JackDavidSchimMDFAHS

Neurology • Carlsbad, CA

Headache

Chair of the Division of Neuroscience at Scripps Hospital. Medical Director of the Stroke Program at Tri-City Medical Center.

Join to view full profile

Dr. Schim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schim's full profile

Already have an account?

Office
6010 Hidden Valley Rd
Ste 200
Carlsbad, CA 92011
Phone+1 760-631-3000

Fax+1 760-631-3016

Education & Training

University of California (San Diego) Medical CenterResidency, Neurology, 1982 - 1985
Cedars-Sinai Medical CenterInternship, Internal Medicine, 1981 - 1982
University of California San Diego School of MedicineClass of 1981

Certifications & Licensure

CA State Medical License 1982 - 2025
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Top MD Consumers Checkbook

Publications & Presentations

PubMed

Long-term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis ...
Anna Gryglas-Dworak, Jack Schim, Anders Ettrup, Line Pickering Boserup, Mette Krog Josiassen
Headache. 2024-11-05
1 citations
Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study.
Robert P Cowan, Michael J Marmura, Hans-Christoph Diener, Amaal J Starling, Jack Schim
The Journal of Headache and Pain. 2022-09-06
3 citations
Likelihood of response with subsequent dosing for patients with migraine and initial suboptimal response with eptinezumab: A post hoc analysis of two placebo-controlle...
Jack D Schim, Carlton Anderson, Elizabeth Brunner, Joe Hirman, Annette Ogbru
Headache. 2022-05-01

Press Mentions

Upsher-Smith Reimagines Prescriber Education with Launch of Migraine PeerConnectDecember 8th, 2020
Alder BioPharmaceuticals® to Present New Analyses of Eptinezumab’s Clinical Trial Data Describing Early, Robust Migraine Prevention and Quality of Life Impact at 2019 American Academy of Neurology Annual MeetingApril 23rd, 2019
Pure Tension-Type Headache Versus Tension-Type Headache in the MigraineurSeptember 28th, 2010